Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine
β Scribed by Joseph F. Foss; Chun-Su Yuan; Michael F. Roizen; Leon I. Goldberg
- Book ID
- 105994382
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 136 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Chemotherapy-induced emesis is one of the most disturbing side effects of cancer therapy. Control of acute emesis has improved substantially during recent years, but control of delayed emesis and nausea remains a challenging problem. The role of 5-HT3 receptor antagonists in the tre
## Abstract ## BACKGROUND Recent studies have suggested that antiemetic therapy with a triple combination of the neurokininβ1 receptor antagonist MKβ869, a serotonin (5βHT~3~) antagonist, and dexamethasone provides enhanced control of cisplatinβinduced emesis compared with standard therapy regimen